Charles River Laboratories Announces Third-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Charles River Labs (CRL) PT Raised to $147 at RBC Capital
November 8, 2018 7:01 AM ESTRBC Capital analyst George Hill raised the price target on Charles River Labs (NYSE: CRL) to $147.00 (from $131.00) while maintaining an Outperform rating following Q3 results, which beat on EPS and revenue though margin missed.
"We believe the miss was largely a... More
Charles River Laboratories (CRL) Tops Q3 EPS by 15c
November 7, 2018 7:03 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the... More
